Suchergebnisse - (Person:"Sun, Jing")

PubPharm (88)

1

Invasive pneumococcal diseases in Chinese children : a multicentre hospital-based active surveillance from 2019 to 2021

enthalten in: Emerging microbes & infections | 2024

von Ning, X. | Li, L. | Liu, J. | +38

2

Clinical manifestation, lifestyle, and treatment patterns of chronic erosive gastritis : A multicenter real-world study in China

enthalten in: World journal of gastroenterology | 2024

von Yang, Y. | Li, K. | Xu, G. | +18

3

Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy : The SURPASS Study

enthalten in: Clinical lung cancer | 2023

von Zhao, S. | Chen, K. | Shi, X. | +4

4

Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation : A Multicenter Randomized Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Ling, Y. | Xuan, L. | Xu, N. | +20

5

Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation : a multi-center, cohort study

enthalten in: Signal transduction and targeted therapy | 2023

von Shao, R. | Zhang, Y. | He, J. | +26

6

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia : long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Xuan, L. | Wang, Y. | Yang, K. | +21

CommentIn: Lancet Haematol. 2023 Aug;10(8):e559-e561. - PMID 37532412

7

Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH) : a multicentre, open-label, randomised phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Young, G. | Srivastava, A. | Kavakli, K. | +12

CommentIn: Lancet. 2023 Apr 29;401(10386):1400-1401. - PMID 37003290

8

Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate-risk acute myeloid leukemia in first complete remission undergoing auto-HSCT : An open-label, multicenter, randomized phase 3 trial

enthalten in: American journal of hematology | 2023

von Liu, H. | Huang, F. | Zhang, Y. | +16

9

The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation : an open-label, multicentre, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Xuan, L. | Dai, M. | Jiang, E. | +17

CommentIn: Lancet Haematol. 2023 Mar;10(3):e159-e160. - PMID 36702139

10

Comparison of anal pre-cancer screening strategies among men who have sex with men

enthalten in: International journal of STD & AIDS | 2023

von Sun, J. | Wiley, D. | Barrett, B. | +5

1
2
3
4
5
6
7
8
9
Nächster »
[9]